Trial Profile
A study evaluating efficacy of Ramelteon for treatment of elderly patients with delirium in general hospital setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2017
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 27 Sep 2017 New trial record
- 20 Sep 2017 Primary endpoint (Decrease in need for PRN antipsychotics) has been met as per the results published in the Clinical Drug Investigation
- 20 Sep 2017 Results published in the Clinical Drug Investigation